AFG
WST icon

Atomi Financial Group’s West Pharmaceutical WST Stock Holding History

Atomi Financial Group’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$467K Buy
1,301
+77
+6% +$23.5K 0.01% 804
2026
Q1 		$307K Buy
1,224
+43
+4% +$10.7K 0.01% 937
2025
Q4 		$325K Sell
1,181
-58
-5% -$15.9K 0.01% 895
2025
Q3 		$325K Buy
+1,239
New +$301K 0.01% 847
2025
Q1 		– Sell
-817
Closed -$267K – 1127
2024
Q4 		$267K Buy
817
+140
+21% +$44.1K 0.01% 780
2024
Q3 		$203K Sell
677
-20
-3% -$6.13K 0.01% 850
2024
Q2 		$230K Buy
697
+94
+16% +$33.2K 0.02% 692
2024
Q1 		$239K Buy
+603
New +$223K 0.02% 617

Other funds holding WST

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
GIM
Generation Investment Management London, United Kingdom $10.3B AUM 4.84% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

Atomi Financial Group's WST Position: Q2 2026 in Review

Atomi Financial Group increased its West Pharmaceutical (WST) stake by 6.3% in Q2 2026, buying an estimated $23.5K and bringing the position to 1,301 shares worth $467K. The position accounts for 0.01% of the portfolio, ranked #804.

Atomi Financial Group first reported a position in WST in Q1 2024 and has held it in 8 quarters since. 830 funds tracked by Wall St. Rank hold WST as of Q2 2026.

  • Atomi Financial Group held 1,301 shares of West Pharmaceutical worth $467K as of Q2 2026.
  • Atomi Financial Group bought 77 West Pharmaceutical shares in Q2 2026, an estimated $23.5K.
  • West Pharmaceutical made up 0.01% of Atomi Financial Group's portfolio in Q2 2026, its #804 holding.
  • Atomi Financial Group first reported a position in West Pharmaceutical in Q1 2024 and has held it in 8 quarters since.
  • 830 funds tracked by Wall St. Rank held West Pharmaceutical as of Q2 2026.

Based on Atomi Financial Group's 13F filing for Q2 2026, filed 4 Aug 2026.